Growth Metrics

Cryoport (CYRX) EBIAT (2016 - 2026)

Cryoport has reported EBIAT over the past 17 years, most recently at -$9.4 million for Q1 2026.

  • Quarterly EBIAT fell 39.98% to -$9.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$39.8 million through Mar 2026, up 62.63% year-over-year, with the annual reading at $78.3 million for FY2025, 168.23% up from the prior year.
  • EBIAT was -$9.4 million for Q1 2026 at Cryoport, up from -$11.6 million in the prior quarter.
  • Over five years, EBIAT peaked at $3.9 million in Q3 2024 and troughed at -$76.4 million in Q2 2024.
  • The 5-year median for EBIAT is -$11.6 million (2025), against an average of -$17.8 million.
  • Year-over-year, EBIAT plummeted 561.18% in 2023 and then surged 129.54% in 2024.
  • A 5-year view of EBIAT shows it stood at -$9.4 million in 2022, then plummeted by 561.18% to -$62.4 million in 2023, then surged by 56.37% to -$27.2 million in 2024, then soared by 57.22% to -$11.6 million in 2025, then increased by 19.0% to -$9.4 million in 2026.
  • Per Business Quant, the three most recent readings for CYRX's EBIAT are -$9.4 million (Q1 2026), -$11.6 million (Q4 2025), and -$6.7 million (Q3 2025).